Silicon Valley Bank released a mid-year update to its Trends in Healthcare Investments and Exits report on September 4th. The report summarized a first half of 2015 which saw continued strength in both initial public offerings (IPOs) and mergers & acquisitions (M&A).

There were 24 biopharma IPOs during the first half of 2015, a sustained level of activity that, according to SVB, showed that 2015 would wind up a third consecutive year of strong activity.

For more on this study, visit the CTC Research page here.